Orion is a globally operating Finnish developer of pharmaceuticals and diagnostic tests – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. It is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory for which Orion developes inhaled Easyhaler® pulmonary drugs.

from http://www.orion.fi/en/

Publications show all

Orion Corporation has published 208 articles.

Patents show all


Clinical Trials show all

47Phase 116Phase 312Phase 212Phase 410N/A8Other

Contact Information